BACKGROUND: Dickkopf-1 (DKK1), a secreted protein known as a negative regulator of the Wnt signaling pathway, has been implicated in tumorigenesis. However, the clinical significance of DKK1 in gastric cancer has not been clarified. METHODS: Serum concentrations of DKK1 in 153 patients with gastric cancer and 173 healthy controls were assessed. For tissue DKK1, immunohistochemistry was performed in 144 cancer specimens from 153 patients and in an additional 265 consecutive gastric cancer specimens. RESULTS: The serum DKK1 concentrations were significantly higher in the gastric cancer patients than in the healthy controls (p<0.001). At a cutoff concentration of 31.9150 pg/ml, the sensitivity and the specificity for gastric cancer diagnosis were 87.6% and 87.9%, respectively. The gastric cancer patients with a serum DKK1 level of ≥ 60.0 pg/ml had significantly diminished survival compared with the patients whose serum DKK1 levels were lower (p=0.033). The DKK1 overexpression in the cancer specimens significantly correlated with the increased serum DKK1 concentrations. CONCLUSIONS: Serum DKK1 levels have the potential as a diagnostic marker at a low cutoff value and as a prognostic marker at a high cutoff value. Serum and tissue DKK1 levels may aid in diagnosing gastric cancer and predicting patient outcomes.
BACKGROUND:Dickkopf-1 (DKK1), a secreted protein known as a negative regulator of the Wnt signaling pathway, has been implicated in tumorigenesis. However, the clinical significance of DKK1 in gastric cancer has not been clarified. METHODS: Serum concentrations of DKK1 in 153 patients with gastric cancer and 173 healthy controls were assessed. For tissue DKK1, immunohistochemistry was performed in 144 cancer specimens from 153 patients and in an additional 265 consecutive gastric cancer specimens. RESULTS: The serum DKK1 concentrations were significantly higher in the gastric cancerpatients than in the healthy controls (p<0.001). At a cutoff concentration of 31.9150 pg/ml, the sensitivity and the specificity for gastric cancer diagnosis were 87.6% and 87.9%, respectively. The gastric cancerpatients with a serum DKK1 level of ≥ 60.0 pg/ml had significantly diminished survival compared with the patients whose serum DKK1 levels were lower (p=0.033). The DKK1 overexpression in the cancer specimens significantly correlated with the increased serum DKK1 concentrations. CONCLUSIONS: Serum DKK1 levels have the potential as a diagnostic marker at a low cutoff value and as a prognostic marker at a high cutoff value. Serum and tissue DKK1 levels may aid in diagnosing gastric cancer and predicting patient outcomes.
Authors: Allison L Kuipers; Shibing Yu; Candace M Kammerer; Cara S Nestlerode; Clareann H Bunker; Alan L Patrick; Victor W Wheeler; Yingze Zhang; Joseph M Zmuda Journal: Calcif Tissue Int Date: 2014-12-31 Impact factor: 4.333
Authors: Hye Seung Lee; Sang Mee Hwang; Taek Soo Kim; Duck-Woo Kim; Do Joong Park; Sung-Bum Kang; Hyung-Ho Kim; Kyoung Un Park Journal: Transl Oncol Date: 2013-06-01 Impact factor: 4.243
Authors: Patrizia D'Amelio; Ilaria Roato; Marco Oderda; Francesco Soria; Andrea Zitella; Riccardo Ferracini; Giulio Mengozzi; Paolo Gontero; Giovanni Carlo Isaia Journal: BMC Clin Pathol Date: 2014-03-21
Authors: Soon Auck Hong; Su Hyun Yoo; Han Hong Lee; Der Sheng Sun; Hye Sung Won; Okran Kim; Yoon Ho Ko Journal: BMC Cancer Date: 2018-05-02 Impact factor: 4.430